Association of the Parainfluenza Virus Fusion Hemagglutinin-Neuraminidase Glycoproteins on Cell Surfaces

Journal of Virology

Volumn 71, Issue 1, 1997, Pages 650-656

  Yao, Qizhi ^a   Xiaolei, H U ^a,b   Compans, Richard W ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HN PROTEIN; PLASMID DNA; VIRUS FUSION PROTEIN; VIRUS GLYCOPROTEIN;

ARTICLE; CELL FUSION; DNA TRANSFECTION; ELECTROPHORETIC MOBILITY; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; PARAINFLUENZA VIRUS; PARAINFLUENZA VIRUS 1; PARAINFLUENZA VIRUS 3; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SENDAI VIRUS; SIMIAN VIRUS; VACCINIA VIRUS;

ANIMALS; CELL MEMBRANE; ELECTROPHORESIS; GENE EXPRESSION; HELA CELLS; HN PROTEIN; HUMANS; MEMBRANE FUSION; PARAINFLUENZA VIRUS 1, HUMAN; PARAINFLUENZA VIRUS 2, HUMAN; PARAINFLUENZA VIRUS 3, HUMAN; PRECIPITIN TESTS; RABBITS; RECEPTORS, CELL SURFACE; RESPIROVIRUS; VIRAL FUSION PROTEINS;

EID: 0031060164     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.1.650-656.1997     Document Type: Article

References (51)

1. Bagai, S., and R. A. Lamb. 1995. Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus. J. Virol. 69:6712-6710.
2. Bousse, T., T. Takimoto, W. L. Gorman, T. Takahashi, and A. Portner. 1994. Regions on the hemagglutinin-neuraminidase proteins of human parainfluenza virus type 1 and Sendai virus important for membrane fusion. Virology 204:506-514.
3. Buckland, R., E. Malvoisin, P. Beauverger, and F. Wild. 1902. A leucine zipper structure present in the measles virus fusion protein is not required for its tetramerization but is essential for fusion. J. Gen. Virol. 73:1703-1707.
4. Bullough, P. A., F. M. Hughson, J. J. Skehel, and D. C. Wiley. 1904. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature (London) 371:37-43.
5. Carr, C. M., and P. S. Kim. 1993. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell 73:823-832.
6. Cattaneo, R., and J. K. Rose. 1993. Cell fusion by the envelope glycoproteins of persistent measles viruses, which caused lethal human brain disease. J. Virol. 67:1403-1502.
7. Choppin, P. W., and A. Scheid. 1980. The role of viral glycoproteins in adsorption, penetration and pathogenicity of viruses. Rev. Infect. Dis. 2:40-61.
8. Choppin, P. W., and R. W. Compans. 1975. Reproduction of paramyxoviruses, p. 95-178. In R. R. Wagner and H. Fraenkel-Conrat (ed.), Comprehensive virology. Plenum Press, New York.
9. Deng, R., Z. Wang, A. M. Mirza, and R. M. Iorio. 1995. Localization of a domain on the paramyxovirus attachment protein required for the promotion of cellular fusion by its homologous fusion protein spike. Virology 209:457-460.
10. Ebata, S. N., M.-J. Cote, C. Y. Kang, and K. Dimock. 1991. The fusion and hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus 3 are both required for fusion. Virology 183:437-441.
11. Fuerst, T. R., E. G. Niles, F. W. Studier, and B. Moss. 1986. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83:8122-8126.
12. Gorman, W. L., D. S. Gill, R. A. Scroggs, and A. Portner. 1990. The hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus type 1 and Sendai virus have high structure-function similarity with limited antigenic cross-reactivity. Virology 175:211-221.
13. Heminway, B. R., Y. Yu, and M. S. Galinsky. 1994. Paramyxovirus mediated cell fusion requires co-expression of both the fusion and hemagglutinin-neuraminidase glycoproteins. Virus Res. 31:1-16.
14. Homma, M., and M. Ohuchi. 1973. Trypsin action on the growth of Sendai virus in tissue culture cells. III. Structural differences of Sendai viruses grown in eggs and tissue culture cells. J. Virol. 12:1457-1463.
15. Horvath, C. M., R. G. Paterson, M. A. Shaughnessy, R. Wood, and R. A. Lamb. 1992. Biological activity of paramyxovirus fusion proteins: factors influencing formation of syncytia. J. Virol. 66:4564-4569.
16. Hsu, M.-C., A. Scheid, and P. W. Choppin. 1981. Activation of the Sendai virus fusion protein (F) involved a conformational change with exposure of a new hydvophobic region. J. Biol. Chem. 256:3557-3563.
17. Hu, X., R. Ray, and R. W. Compans. 1992. Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses. J. Virol. 66:1528-1535.
18. Joseph, B. S., and M. B. A. Oldstone. 1974. Antibody-induced redistribution of measles virus antigens on the cell surface. J. Immunol. 113:1205-1209.
19. Kohama, T., W. Garten, and H.-D. Klenk. 1981. Changes in conformation and charge paralleling proteolytic activation of Newcastle disease virus glycoproteins. Virology 111:364-376.
20. Lamb, R. A. 1993. Paramyxovirus fusion: a hypothesis for changes. Virology 197:1-11.
21. Lamb, R. A., and D. Kolakofsky. 1996. Paramyxoviridae: the viruses and their replication, p. 1177-1204. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Virology, vol. 1. Lippincott-Raven, New York.
22. Lambert, D. M., S. Barney, A. L. Lambert, K. Guthrie, R. Medinas, D. E. Davis, T. Bucy, J. Erickson, G. Merutka, and S. R. J. Petteway. 1996. Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc. Natl. Acad. Sci. USA 93:2186-2191.
23. Lisanti, M. P., A. Le Bivic, M. Sargiacomo, and E. Rodriguez-Boulan. 1989. Steady-state distribution and biogenesis of endogenous Madin-Darby canine kidney glycoproteins: evidence for intracellular sorting and polarized cell surface delivery. J. Cell Biol. 109:2117-2127.
24. Lydy, S. L., S. Basak, and R. W. Compans. 1990. Host cell-dependent lateral mobility of viral glycoproteins. Microbial. Pathol. 9:375-386.
25. Malvoisin, E., and T. F. Wild. 1993. Measles virus glycoproteins: studies in the structure and interaction of the hemagglutinin and fusion proteins. J. Gen. Virol. 74:2365-2372.
26. Marsh, M., and A. Helenius. 1989. Viral entry into animal cells. Adv. Virus Res. 36:107-151.
27. Matsuoka, Y., R. Ray, and R. W. Compans. 1990. Sequence of the hemagglutinin-neuraminidase gene of human parainfluenza virus type 1. Virus Res. 16:107-113.
28. Morrison, T., C. McQuain, and L. McGinnes. 1991. Complementation between a virulent Newcastle disease virus and a fusion protein gene expressed from a retrovirus vector: requirement for membrane fusion. J. Virol. 65:813-822.
29. Moscona, A., and R. Peluso. 1992. Fusion properties of cells infected with human parainfluenza virus type 3: receptor requirements for viral spread and virus-mediated membrane fusion. J. Virol. 66:6280-6287.
30. Moscona, A., and R. W. Peluso. 1991. Fusion properties of cells persistently infected with human parainfluenza virus type 3: participation of hemagglutinin-neuraminidase in membrane fusion. J. Virol. 65:2773-2777.
31. Ohnishi, S.-I. 1988. Fusion of viral envelopes with cellular membranes. Curr. Top. Membr. Transp. 29:257-296.
32. Paterson, R. G., M. S. Shaughnessy, and R. A. Lamb. 1989. Analysis of the relationship between cleavability of paramyxovirus fusion protein and length of the connecting peptide. J. Virol. 63:1293-1301.
33. Rapaport, D., M. Ovadia, and Y. Shai. 1995. A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: an emerging similarity with functional domains of other viruses. EMBO J. 14:5524-5531.
34. Ray, R., V. E. Brown, and R. W. Compans. 1985. Glycoproteins of human parainfluenza type 3 virus: characterization and evaluation as a subunit vaccine. J. Infect. Dis. 152:1219-1230.
35. Ray, R., and R. W. Compans. 1987. Glycoproteins of human parainfluenza virus type 3: Affinity purification, antigenic characterization, and reconstitution into lipid vesicles. J. Gen. Virol. 68:409-418.
36. Ray, R., and R. W. Compans. 1986. Monoclonal antibodies reveal extensive antigenic differences between the hemagglutinin-neuraminidase glycoproteins of human and bovine parainfluenza 3 viruses. Virology 148:232-236.
37. Reitter, J. N., T. Sergel, and T. G. Morrison. 1995. Mutational analysis of the leucine zipper motif in the Newcastle disease virus fusion protein. J. Virol. 69:5995-6004.
38. Sanderson, C. M., H.-H. Wu, and D. P. Nayak. 1994. Sendai virus M protein binds independently to either the F or the HN glycoprotein in vivo. J. Virol. 68:69-76.
39. Scheid, A., and P. W. Choppin. 1974. Identification and biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity by proteolytic cleavage of an inactive precursor protein of Sendai virus. Virology 57:475-490.
40. Sergel, T., L. W. McGinnes, M. E. Peeples, and T. G. Morrison. 1993. The attachment function of the Newcastle disease virus hemagglutinin-neuraminidase protein can be separated from fusion promotion by mutation. Virology 193:717-726.
41. Sergel, T. G., C. McQuain, and T. G. Morrison. 1994. Mutations in the fusion peptide and heptad repeal regions of the Newcastle disease virus fusion protein block fusion. J. Virol. 68:7654-7658.
42. Tanabayashi, K., and R. W. Compans. 1996. Functional interaction of paramyxovirus glycoproteins: identification of a domain in Sendai virus HN which promotes cell fusion. J. Virol. 70:6112-6118.
43. Tanabayashi, K., K. Takeuchi, K. Okazaki, M. Hishiyama, and A. Yamada. 1992. Expression of mumps virus glycoproteins in mammalian cells from cloned cDNAs: both F and HN proteins are required for cell fusion. Virology 187:801-804.
44. Tanaka, Y., B. R. Heminway, and M. S. Galinski. 1996. Down-regulation of paramyxovirus hemagglutinin-neuraminidase glycoprotein surface expression by a mutant fusion protein containing a retention signal for the endoplasmic reticulum. J. Virol. 70:5005-5015.
45. Taylor, J., S. Pincus, J. Tartaglia, C. Richardson, G. Alkhatib, D. Briedis, M. Appel, E. Norton, and E. Paoletti. 1991. Vaccinia virus recombinants expressing either the measles virus fusion or hemagglutinin glycoprotein protect dogs against canine distemper virus challenge. J. Virol. 65:4263-4274.
46. Tsurudome, M., M. Kawano, T. Yuasa, N. Tahata, M. Nishino, H. Komuda, and Y. Ito. 1995. Identification of regions on the hemagglutinin-neuraminidase protein of human parainfluenza virus type 2 important for promoting cell fusion. Virology 213:190-203.
47. White, J. M. 1992. Membrane fusion. Science 258:917-924.
48. Wild, T. F., J. Fayolle, P. Beauverger, and R. Buckland. 1994. Measles virus fusion: role of the cysteine-rich region of the fusion glycoprotein. J. Virol. 68:7546-7548.
49. Wild, T. F., E. Malvoisin, and R. Buckland. 1991. Measles virus: both the hemagglutinin and fusion glycoproteins are required for fusion. J. Gen. Virol. 72:439-442.
50. Yao, Q., and R. W. Compans. 1995. Differences in the role of the cytoplasmic domain of human parainfluenza virus fusion proteins. J. Virol. 69:7045-7053.
51. Yao, Q., and R. W. Compans. 1996. Peptides corresponding to the heptad repeat sequences of human parainfluenza virus fusion protein are potent inhibitors of virus infection. Virology 223:103-112.